{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:23Z","timestamp":1740136343727,"version":"3.37.3"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pandemic spread of coronavirus (COVID-19) has been reported first at the end of 2019. It continues disturbing various human aspects with multiple pandemic waves showing more fatal novel variants. Now Egypt faces the sixth wave of the pandemic with controlled governmental measures. COVID-19 is an infectious respiratory disease-causing mild to moderate illness that can be progressed into life-threatening complications based on patients- and variant type-related factors. The symptoms vary from dry cough, fever to difficulty in breathing that required urgent hospitalization. Most countries have authorized their national protocols for managing manifested symptoms and thus lowering the rate of patients\u2019 hospitalization and boosting the healthcare systems. These protocols are still in use even with the development and approval of several vaccines. These protocols were instructed to aid home isolation, bed rest, dietary supplements, and additionally the administration of antipyretic, steroids, and antiviral drugs. The current review aimed to highlight the administered protocols in the Middle East, namely in Egypt and the Kingdom of Saudi Arabia demonstrating how these protocols have shown potential effectiveness in treating patients and saving many soles.<\/jats:p>","DOI":"10.1007\/s10787-022-01050-7","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T08:03:09Z","timestamp":1661500989000},"page":"1935-1954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols"],"prefix":"10.1007","volume":"30","author":[{"given":"Engy","family":"Elekhnawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0463-8047","authenticated-orcid":false,"given":"Walaa A.","family":"Negm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzy A.","family":"El-Sherbeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"1050_CR2","volume-title":"Vitamin C (ascorbic acid)","author":"M Abdullah","year":"2020","unstructured":"Abdullah M, Jamil RT, Attia FN (2020) Vitamin C (ascorbic acid). StatPearls [Internet]"},{"issue":"1","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-020-4122-9","volume":"21","author":"B Abiri","year":"2020","unstructured":"Abiri B, Vafa M (2020) Effects of vitamin D and\/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial. Trials 21(1):1\u20137","journal-title":"Trials"},{"key":"1050_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2020.08.004","author":"U Agrawal","year":"2020","unstructured":"Agrawal U, Raju R, Udwadia ZF (2020) Favipiravir: a new and emerging antiviral option in COVID-19. Med J Armed Forces India. https:\/\/doi.org\/10.1016\/j.mjafi.2020.08.004","journal-title":"Med J Armed Forces India"},{"unstructured":"Al Amin A, Gupta V (2020) Vitamin B12 (Cobalamin).https:\/\/europepmc.org\/article\/nbk\/nbk559132","key":"1050_CR5"},{"key":"1050_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.04.016","author":"AA Algaissi","year":"2020","unstructured":"Algaissi AA, Alharbi NK, Hassanain M, Hashem AM (2020a) Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health. https:\/\/doi.org\/10.1016\/j.jiph.2020.04.016","journal-title":"J Infect Public Health"},{"issue":"5","key":"1050_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233147","volume":"15","author":"JS Alqahtani","year":"2020","unstructured":"Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE 15(5):e0233147","journal-title":"PLoS ONE"},{"key":"1050_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104228","volume":"145","author":"J Andreani","year":"2020","unstructured":"Andreani J, Le Bideau M, Duflot I, Jardot P, Rolland C, Boxberger M, Wurtz N, Rolain J-M, Colson P, La Scola B (2020) In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog 145:104228","journal-title":"Microb Pathog"},{"issue":"6","key":"1050_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","volume":"160","author":"YM Arabi","year":"2014","unstructured":"Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B (2014) Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160(6):389\u2013397","journal-title":"Ann Intern Med"},{"key":"1050_CR10","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.12559","author":"AM Armanian","year":"2014","unstructured":"Armanian AM, Badiee Z, Afghari R, Salehimehr N, Hassanzade A, Sheikhzadeh S, Tehrani MS, Rezvan G (2014) Prophylactic aminophylline for prevention of apnea at higher-risk preterm neonates. Iran Red Crescent Med J. https:\/\/doi.org\/10.5812\/ircmj.12559","journal-title":"Iran Red Crescent Med J"},{"issue":"13","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jama.2020.17101","volume":"324","author":"J Avorn","year":"2020","unstructured":"Avorn J, Kesselheim A (2020) Regulatory decision-making on COVID-19 vaccines during a public health emergency. JAMA 324(13):1284\u20131285","journal-title":"JAMA"},{"issue":"6","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1080\/14767058.2019.1619688","volume":"34","author":"MA Bachnas","year":"2021","unstructured":"Bachnas MA, Akbar MIA, Dachlan EG, Dekker G (2021) The role of magnesium sulfate (MgSO4) in fetal neuroprotection. J Matern Fetal Neonatal Med 34(6):966\u2013978","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"14","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA 323(14):1406\u20131407","journal-title":"JAMA"},{"key":"1050_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1826316","author":"R Barrett","year":"2020","unstructured":"Barrett R, Catangui E, Scott R (2020) Acute oxygen therapy: a cross-sectional study of prescribing practices at an english hospital immediately before COVID-19 pandemic. Expert Rev Respir Med. https:\/\/doi.org\/10.1080\/17476348.2021.1826316","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jaci.2014.10.001","volume":"135","author":"A Beigelman","year":"2015","unstructured":"Beigelman A, Isaacson-Schmid M, Sajol G, Baty J, Rodriguez OM, Leege E, Lyons K, Schweiger TL, Zheng J, Schechtman KB (2015) Randomized trial to evaluate azithromycin\u2019s effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 135(5):1171-1178.e1171","journal-title":"J Allergy Clin Immunol"},{"key":"1050_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8560871","author":"A Bharara","year":"2016","unstructured":"Bharara A, Grossman C, Grinnan D, Syed A, Fisher B, DeWilde C, Natarajan R (2016) Intravenous vitamin C administered as adjunctive therapy for recurrent acute respiratory distress syndrome. Case Rep Crit Care. https:\/\/doi.org\/10.1155\/2016\/8560871","journal-title":"Case Rep Crit Care"},{"issue":"10","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00383-005-1538-y","volume":"21","author":"\u00dc Bi\u00e7ak\u00e7i","year":"2005","unstructured":"Bi\u00e7ak\u00e7i \u00dc, Tander B, Arit\u00fcrk E, Aydin BK, Aydin O, Rizalar R, Eren Z, Bernay F (2005) Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia\/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 21(10):800\u2013805","journal-title":"Pediatr Surg Int"},{"key":"1050_CR18","volume-title":"Azithromycin for COVID-19: more than just an antimicrobial?","author":"N Bleyzac","year":"2020","unstructured":"Bleyzac N, Goutelle S, Bourguignon L, Tod M (2020) Azithromycin for COVID-19: more than just an antimicrobial? Springer"},{"key":"1050_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104541","volume":"169","author":"AJ Brown","year":"2019","unstructured":"Brown AJ, Won JJ, Graham RL, Dinnon KH III, Sims AC, Feng JY, Cihlar T, Denison MR, Baric RS, Sheahan TP (2019) Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res 169:104541","journal-title":"Antiviral Res"},{"key":"1050_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00515-6","volume":"2","author":"P Budhathoki","year":"2020","unstructured":"Budhathoki P, Shrestha DB, Rawal E, Khadka S (2020) Corticosteroids in COVID-19: is it rational? A systematic review and meta-analysis. SN Compr Clin Med 2:1\u201321","journal-title":"SN Compr Clin Med"},{"issue":"10","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","volume":"6","author":"Q Cai","year":"2020","unstructured":"Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X, Gu Y, Cai Q, Yang Y (2020) Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering 6(10):1192\u20131198","journal-title":"Engineering"},{"key":"1050_CR22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M (2020a) A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2001282","journal-title":"N Engl J Med"},{"key":"1050_CR23","volume-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open forum infectious diseases","author":"W Cao","year":"2020","unstructured":"Cao W, Liu X, Bai T, Fan H, Hong K, Song H, Han Y, Lin L, Ruan L, Li T (2020b) High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open forum infectious diseases. Oxford University Press US"},{"issue":"11","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/nu9111211","volume":"9","author":"AC Carr","year":"2017","unstructured":"Carr AC, Maggini S (2017) Vitamin C and immune function. Nutrients 9(11):1211","journal-title":"Nutrients"},{"key":"1050_CR25","volume-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"M Cascella","year":"2022","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R (2022) Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls [internet]"},{"issue":"5","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H (2020a) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig 130(5):2620\u20132629","journal-title":"J Clin Investig"},{"issue":"10223","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y (2020b) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513","journal-title":"Lancet"},{"issue":"1\u20132","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000362724","volume":"22","author":"D Cruz-Topete","year":"2015","unstructured":"Cruz-Topete D, Cidlowski JA (2015) One hormone, two actions: anti-and pro-inflammatory effects of glucocorticoids. NeuroImmunoModulation 22(1\u20132):20\u201332","journal-title":"NeuroImmunoModulation"},{"key":"1050_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1375","author":"M Day","year":"2020","unstructured":"Day M (2020) Covid-19: four fifths of cases are asymptomatic, China figures indicate. Br Med J Publ Group. https:\/\/doi.org\/10.1136\/bmj.m1375","journal-title":"Br Med J Publ Group"},{"issue":"24","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1001\/jama.2020.8711","volume":"323","author":"SS DeRoo","year":"2020","unstructured":"DeRoo SS, Pudalov NJ, Fu LY (2020) Planning for a COVID-19 vaccination program. JAMA 323(24):2458\u20132459","journal-title":"JAMA"},{"issue":"5","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20(5):533\u2013534","journal-title":"Lancet Infect Dis"},{"key":"1050_CR32","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3389\/fphar.2020.579886","volume":"11","author":"F Drago","year":"2020","unstructured":"Drago F, Gozzo L, Li L, Stella A, Cosmi B (2020) Use of enoxaparin to counteract COVID-19 infection and reduce thromboembolic venous complications: a review of the current evidence. Front Pharmacol 11:1469","journal-title":"Front Pharmacol"},{"issue":"1","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/rth2.12283","volume":"4","author":"B Driver","year":"2020","unstructured":"Driver B, Marks DC, van der Wal DE (2020) Not all (N) SAID and done: effects of nonsteroidal anti-inflammatory drugs and paracetamol intake on platelets. Res Pract Thromb Haemost 4(1):36\u201345","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbrc.2019.11.065","volume":"522","author":"X Du","year":"2020","unstructured":"Du X, Zuo X, Meng F, Wu F, Zhao X, Li C, Cheng G, Qin FX-F (2020) Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities. Biochem Biophys Res Commun 522(4):862\u2013868","journal-title":"Biochem Biophys Res Commun"},{"unstructured":"Duffy E (2022) Treating COVID-19 with Paxlovid in primary care. https:\/\/www.akohiringa.co.nz\/education\/treating-covid-19-with-paxlovid-in-primary-care","key":"1050_CR35"},{"issue":"2","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2020.1813024","volume":"19","author":"D Echeverr\u00eda-Esnal","year":"2021","unstructured":"Echeverr\u00eda-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, De-Antonio Cusc\u00f3 M, Ferr\u00e1ndez O, Horcajada JP, Grau S (2021) Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther 19(2):147\u2013163","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1050_CR37","volume-title":"N acetylcysteine","author":"M Ershad","year":"2019","unstructured":"Ershad M, Vearrier D (2019) N acetylcysteine. StatPearls [Internet]"},{"issue":"2","key":"1050_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/tbed.13819","volume":"68","author":"G Fan","year":"2021","unstructured":"Fan G, Yang Z, Lin Q, Zhao S, Yang L, He D (2021) Decreased case fatality rate of COVID-19 in the second wave: a study in 53 countries or regions. Transbound Emerg Dis 68(2):213\u2013215","journal-title":"Transbound Emerg Dis"},{"issue":"9","key":"1050_CR39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805","journal-title":"N Engl J Med"},{"key":"1050_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.17.21258639","author":"W Fischer","year":"2021","unstructured":"Fischer W, Eron JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR (2021a) Molnupiravir, an oral antiviral treatment for COVID-19. MedRxiv. https:\/\/doi.org\/10.1101\/2021.06.17.21258639","journal-title":"MedRxiv"},{"issue":"628","key":"1050_CR41","doi-asserted-by":"publisher","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","volume":"14","author":"WA Fischer","year":"2021","unstructured":"Fischer WA, Eron JJ Jr, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR (2021b) A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci Transl Med 14(628):eabl7430","journal-title":"Sci Transl Med"},{"issue":"2","key":"1050_CR42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Y Furuta","year":"2013","unstructured":"Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL (2013) Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antivir Res 100(2):446\u2013454","journal-title":"Antivir Res"},{"issue":"11","key":"1050_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/intimm\/dxx039","volume":"29","author":"C Galeotti","year":"2017","unstructured":"Galeotti C, Kaveri SV, Bayry J (2017) IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol 29(11):491\u2013498","journal-title":"Int Immunol"},{"issue":"18","key":"1050_CR44","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"RT Gandhi","year":"2020","unstructured":"Gandhi RT, Lynch JB, Del Rio C (2020) Mild or moderate covid-19. N Engl J Med 383(18):1757\u20131766","journal-title":"N Engl J Med"},{"issue":"11","key":"1050_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30208-5","volume":"5","author":"AL Garc\u00eda-Basteiro","year":"2020","unstructured":"Garc\u00eda-Basteiro AL, Legido-Quigley H, \u00c1lvarez-Dardet C, Arenas A, Bengoa R, Borrell C, Del Val M, Franco M, Gea-S\u00e1nchez M, Gestal J (2020) Evaluation of the COVID-19 response in Spain: principles and requirements. The Lancet Public Health 5(11):e575","journal-title":"The Lancet Public Health"},{"issue":"1","key":"1050_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 56(1):105949","journal-title":"Int J Antimicrob Agents"},{"issue":"25","key":"1050_CR47","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG (2020) Observational study of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med 382(25):2411\u20132418","journal-title":"N Engl J Med"},{"issue":"1","key":"1050_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4717-5","volume":"20","author":"N Gharebaghi","year":"2020","unstructured":"Gharebaghi N, Nejadrahim R, Mousavi SJ, Sadat-Ebrahimi S-R, Hajizadeh R (2020) The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20(1):1\u20138","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1050_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-77748-x","volume":"10","author":"RM Ghazy","year":"2020","unstructured":"Ghazy RM, Almaghraby A, Shaaban R, Kamal A, Beshir H, Moursi A, Ramadan A, Taha SHN (2020) A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Sci Rep 10(1):1\u201318","journal-title":"Sci Rep"},{"issue":"4","key":"1050_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M (2022) Early remdesivir to prevent progression to severe covid-19 in outpatients. N Engl J Med 386(4):305\u2013315","journal-title":"N Engl J Med"},{"issue":"18","key":"1050_CR52","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-J Guan","year":"2020","unstructured":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708\u20131720","journal-title":"N Engl J Med"},{"issue":"4","key":"1050_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/vaccines9040399","volume":"9","author":"A Hagens","year":"2021","unstructured":"Hagens A, \u0130nkaya A\u00c7, Yildirak K, Sancar M, van der Schans J, Acar Sancar A, \u00dcnal S, Postma M, Ye\u011feno\u011flu S (2021) COVID-19 vaccination scenarios: a cost-effectiveness analysis for Turkey. Vaccines 9(4):399","journal-title":"Vaccines"},{"issue":"15","key":"1050_CR54","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Sim\u00f3n-Campos A (2022) Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med 386(15):1397\u20131408","journal-title":"N Engl J Med"},{"issue":"3","key":"1050_CR55","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-018-4850-1","volume":"298","author":"F Han","year":"2018","unstructured":"Han F, Xu L, Huang Y, Chen T, Zhou T, Yang L (2018) Magnesium sulphate can alleviate oxidative stress and reduce inflammatory cytokines in rat placenta of intrahepatic cholestasis of pregnancy model. Arch Gynecol Obstet 298(3):631\u2013638","journal-title":"Arch Gynecol Obstet"},{"issue":"10261","key":"1050_CR56","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(20)32007-9","volume":"396","author":"E Han","year":"2020","unstructured":"Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, Asgari N, Oh J, Garc\u00eda-Basteiro AL, Hanefeld J (2020) Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet 396(10261):1525\u20131534","journal-title":"Lancet"},{"issue":"3","key":"1050_CR57","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7150\/thno.48342","volume":"11","author":"YJ Han","year":"2021","unstructured":"Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J (2021) Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. Theranostics 11(3):1207","journal-title":"Theranostics"},{"issue":"4","key":"1050_CR58","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/vaccines8040739","volume":"8","author":"A Haque","year":"2020","unstructured":"Haque A, Pant AB (2020) Efforts at COVID-19 vaccine development: challenges and successes. Vaccines 8(4):739","journal-title":"Vaccines"},{"issue":"4","key":"1050_CR59","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s11239-020-02235-z","volume":"50","author":"SS Hasan","year":"2020","unstructured":"Hasan SS, Radford S, Kow CS, Zaidi STR (2020) Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis 50(4):814\u2013821","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"1050_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jmv.25424","volume":"91","author":"AM Hashem","year":"2019","unstructured":"Hashem AM, Al-Subhi TL, Badroon NA, Hassan AM, Bajrai LHM, Banassir TM, Alquthami KM, Azhar EI (2019) MERS-CoV, influenza and other respiratory viruses among symptomatic pilgrims during 2014 Hajj season. J Med Virol 91(6):911\u2013917","journal-title":"J Med Virol"},{"issue":"8","key":"1050_CR61","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S1473-3099(20)30319-4","volume":"20","author":"M Hassany","year":"2020","unstructured":"Hassany M, Abdel-Razek W, Asem N, AbdAllah M, Zaid H (2020) Estimation of COVID-19 burden in Egypt. Lancet Infect Dis 20(8):896\u2013897","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"1050_CR62","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","volume":"282","author":"FG Hayden","year":"1999","unstructured":"Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE (1999) Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282(13):1240\u20131246","journal-title":"JAMA"},{"issue":"6","key":"1050_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/wound.2016.0718","volume":"6","author":"M Heyboer III","year":"2017","unstructured":"Heyboer M III, Sharma D, Santiago W, McCulloch N (2017) Hyperbaric oxygen therapy: side effects defined and quantified. Adv Wound Care 6(6):210\u2013224","journal-title":"Adv Wound Care"},{"key":"1050_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.09.025","author":"BX Hoang","year":"2020","unstructured":"Hoang BX, Shaw DG, Fang W, Han B (2020b) A possible application of high dose vitamin C in the prevention and therapy for coronavirus infections. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2020.09.025","journal-title":"J Glob Antimicrob Resist"},{"key":"1050_CR65","volume-title":"Corticosteroids","author":"A Hodgens","year":"2020","unstructured":"Hodgens A, Sharman T (2020) Corticosteroids. StatPearls [Internet]"},{"issue":"7826","key":"1050_CR66","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","volume":"585","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, M\u00f6sbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Kr\u00fcger N, Gassen NC, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature 585(7826):588\u2013590","journal-title":"Nature"},{"issue":"10223","key":"1050_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395(10223):497\u2013506","journal-title":"The Lancet"},{"issue":"10","key":"1050_CR68","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LS (2020) Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 26(10):1395\u20131399","journal-title":"Clin Microbiol Infect"},{"key":"1050_CR69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ (2020) An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N Eng J Med. https:\/\/doi.org\/10.1056\/NEJMoa2022483","journal-title":"N Eng J Med"},{"issue":"6","key":"1050_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Mart\u00edn-Quir\u00f3s A, Caraco Y, Williams-Diaz A, Brown ML (2022) Molnupiravir for oral treatment of covid-19 in nonhospitalized patients. N Engl J Med 386(6):509\u2013520","journal-title":"N Engl J Med"},{"issue":"2","key":"1050_CR71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/idr13020029","volume":"13","author":"F Jirjees","year":"2021","unstructured":"Jirjees F, Saad AK, Al Hano Z, Hatahet T, Al Obaidi H, Dallal Bashi YH (2021) COVID-19 treatment guidelines: do they really reflect best medical practices to manage the pandemic? Infect Dis Rep 13(2):259\u2013284","journal-title":"Infect Dis Rep"},{"key":"1050_CR72","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/fmb-2020-0074","volume":"15","author":"R Jorge-Aar\u00c3n","year":"2020","unstructured":"Jorge-Aar\u00c3n R, Rosa-Ester M (2020) N-acetylcysteine as a potential treatment for novel coronavirus disease 2019. Future Microbiol 15:959\u2013962","journal-title":"Future Microbiol"},{"key":"1050_CR73","volume-title":"Enoxaparin","author":"A Jupalli","year":"2020","unstructured":"Jupalli A, Iqbal AM (2020) Enoxaparin. StatPearls [Internet]"},{"issue":"9","key":"1050_CR74","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","volume":"28","author":"F Kabinger","year":"2021","unstructured":"Kabinger F, Stiller C, Schmitzov\u00e1 J, Dienemann C, Kokic G, Hillen HS, H\u00f6bartner C, Cramer P (2021) Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol 28(9):740\u2013746","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"1050_CR75","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S (2021) Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med 384(9):795\u2013807","journal-title":"N Engl J Med"},{"issue":"7","key":"1050_CR76","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.arcmed.2020.06.004","volume":"51","author":"I Karampela","year":"2020","unstructured":"Karampela I, Dalamaga M (2020) Could respiratory fluoroquinolones, levofloxacin and moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19? Arch Med Res 51(7):741\u2013742","journal-title":"Arch Med Res"},{"issue":"10","key":"1050_CR77","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/17512433.2021.1949286","volume":"14","author":"G Kenny","year":"2021","unstructured":"Kenny G, Mallon PW (2021) Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date. Expert Rev Clin Pharmacol 14(10):1279\u20131287","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"1050_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.08.045","volume":"82","author":"J-P Kevorkian","year":"2021","unstructured":"Kevorkian J-P, Riveline J-P, Vandiedonck C, Girard D, Galland J, F\u00e9ron F, Gautier J-F, M\u00e9garbane B (2021) Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: an observational cohort study. J Infect 82(1):e22","journal-title":"J Infect"},{"issue":"16","key":"1050_CR79","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.3390\/ijerph17165813","volume":"17","author":"SAM Khalifa","year":"2020","unstructured":"Khalifa SAM, Mohamed BS, Elashal MH, Du M, Guo Z, Zhao C, Musharraf SG, Boskabady MH, El-Seedi HHR, Efferth T, El-Seedi HR (2020a) Comprehensive overview on multiple strategies fighting COVID-19. Int J Environ Res Public Health 17(16):5813","journal-title":"Int J Environ Res Public Health"},{"key":"1050_CR80","doi-asserted-by":"publisher","first-page":"153311","DOI":"10.1016\/j.phymed.2020.153311","volume":"85","author":"SAM Khalifa","year":"2020","unstructured":"Khalifa SAM, Yosri N, El-Mallah MF, Ghonaim R, Guo Z, Musharraf SG, Du M, Khatib A, Xiao J, Saeed A, El-Seedi HHR, Zhao C, Efferth T, El-Seedi HR (2020b) Screening for natural and derived bio-active compounds in preclinical and clinical studies: one of the frontlines of fighting the coronaviruses pandemic. Phytomedicine 85:153311","journal-title":"Phytomedicine"},{"issue":"3","key":"1050_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3851\/IMP1937","volume":"17","author":"IA Khan","year":"2012","unstructured":"Khan IA, Siddiqui S, Rehmani S, Kazmi SU, Ali SH (2012) Fluoroquinolones inhibit HCV by targeting its helicase. Antivir Ther 17(3):467","journal-title":"Antivir Ther"},{"key":"1050_CR82","volume-title":"Furosemide","author":"TM Khan","year":"2021","unstructured":"Khan TM, Patel R, Siddiqui AH (2021) Furosemide. StatPearls [Internet]"},{"key":"1050_CR83","first-page":"1062","volume":"9","author":"P Khanal","year":"2020","unstructured":"Khanal P (2020) Remdesivir for COVID-19 treatment: mechanism of action, synthesis, and clinical trials. J Pharm Pharm Sci 9:1062\u20131068","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"1050_CR84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4110\/in.2013.13.2.70","volume":"13","author":"Y Kim","year":"2013","unstructured":"Kim Y, Kim H, Bae S, Choi J, Lim SY, Lee N, Kong JM, Hwang Y-I, Kang JS, Lee WJ (2013) Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-\u03b1\/\u03b2 at the initial stage of influenza A virus (H3N2) infection. Immune Network 13(2):70\u201374","journal-title":"Immune Network"},{"key":"1050_CR85","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1387\/ijdb.150196lr","volume":"59","author":"Y Komiya","year":"2015","unstructured":"Komiya Y, Runnels LW (2015) TRPM channels and magnesium in early embryonic development. Int J Dev Biol 59:281","journal-title":"Int J Dev Biol"},{"issue":"2","key":"1050_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7861\/clinmed.2019-coron","volume":"20","author":"MA Lake","year":"2020","unstructured":"Lake MA (2020) What we know so far: COVID-19 current clinical knowledge and research. Clin Med 20(2):124","journal-title":"Clin Med"},{"key":"1050_CR87","first-page":"339","volume":"20","author":"MA Langarizadeh","year":"2021","unstructured":"Langarizadeh MA, Tavakoli MR, Abiri A, Ghasempour A, Rezaei M, Ameri A (2021) A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms. Excli J 20:339","journal-title":"Excli J"},{"issue":"5","key":"1050_CR88","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"TT Le","year":"2020","unstructured":"Le TT, Andreadakis Z, Kumar A, Rom\u00e1n RG, Tollefsen S, Saville M, Mayhew S (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19(5):305\u2013306","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"1050_CR89","doi-asserted-by":"publisher","first-page":"e00394","DOI":"10.1128\/AAC.00394-19","volume":"63","author":"C Li","year":"2019","unstructured":"Li C, Zu S, Deng Y-Q, Li D, Parvatiyar K, Quanquin N, Shang J, Sun N, Su J, Liu Z (2019) Azithromycin protects against Zika virus infection by upregulating virus-induced type I and III interferon responses. Antimicrob Agents Chemother 63(12):e00394-e1319","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1050_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105951","volume":"55","author":"H Li","year":"2020","unstructured":"Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K (2020a) Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents 55(5):105951","journal-title":"Int J Antimicrob Agents"},{"key":"1050_CR91","first-page":"e0195068","volume":"13","author":"Y Li","year":"2020","unstructured":"Li Y, Xie Z, Lin W, Cai W, Wen C, Guan Y, Mo X, Wang J, Wang Y, Peng P (2020bc) An exploratory randomized, controlled study on the efficacy and safety of lopinavir\/ritonavir or arbidol treating adult patients hospitalized with mild\/moderate COVID-19 (ELACOI). MedRxiv 13:e0195068","journal-title":"MedRxiv"},{"issue":"2","key":"1050_CR92","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jgg.2020.02.001","volume":"47","author":"X Liu","year":"2020","unstructured":"Liu X, Wang X-J (2020) Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J Genet Genom 47(2):119","journal-title":"J Genet Genom"},{"key":"1050_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15073","volume-title":"The use of high-flow nasal oxygen in COVID-19","author":"C Lyons","year":"2020","unstructured":"Lyons C, Callaghan M (2020) The use of high-flow nasal oxygen in COVID-19. Wiley Online Library"},{"issue":"6","key":"1050_CR94","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tips.2020.03.006","volume":"41","author":"MP Lythgoe","year":"2020","unstructured":"Lythgoe MP, Middleton P (2020) Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci 41(6):363\u2013382","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"1050_CR95","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","volume":"55","author":"V Madelain","year":"2016","unstructured":"Madelain V, Nguyen THT, Olivo A, De Lamballerie X, Guedj J, Taburet A-M, Mentr\u00e9 F (2016) Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials. Clin Pharmacokinet 55(8):907\u2013923","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1050_CR96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.26719\/2016.22.2.85","volume":"22","author":"MR Malik","year":"2015","unstructured":"Malik MR, Mahjour J (2015) Closing the knowledge gaps on MERS: three and half years since its detection, what have we learnt and what needs to be done urgently? EMHJ-East Mediterr Health J 22(2):85\u201386","journal-title":"EMHJ-East Mediterr Health J"},{"issue":"9","key":"1050_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238678","volume":"15","author":"G Marois","year":"2020","unstructured":"Marois G, Muttarak R, Scherbov S (2020) Assessing the potential impact of COVID-19 on life expectancy. PLoS ONE 15(9):e0238678","journal-title":"PLoS ONE"},{"issue":"3","key":"1050_CR98","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.pcad.2020.02.007","volume":"63","author":"MF McCarty","year":"2020","unstructured":"McCarty MF, DiNicolantonio JJ (2020) Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis 63(3):383","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"1050_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19(6):102537","journal-title":"Autoimmun Rev"},{"issue":"9934","key":"1050_CR100","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(14)60381-0","volume":"383","author":"ZA Memish","year":"2014","unstructured":"Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, Alyemni M, Dhafar K, Gautret P, Barbeschi M (2014) Hajj: infectious disease surveillance and control. The Lancet 383(9934):2073\u20132082","journal-title":"The Lancet"},{"issue":"5","key":"1050_CR101","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.therap.2020.07.008","volume":"75","author":"J Micallef","year":"2020","unstructured":"Micallef J, Soeiro T, Jonville-B\u00e9ra A-P (2020a) COVID-19 and NSAIDs: primum non nocere. Therapie 75(5):514","journal-title":"Therapie"},{"issue":"4","key":"1050_CR102","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.therap.2020.05.003","volume":"75","author":"J Micallef","year":"2020","unstructured":"Micallef J, Soeiro T, Jonville-B\u00e9ra A-P, F. S. of Pharmacology (2020b) Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. Therapies 75(4):355\u2013362","journal-title":"Therapies"},{"key":"1050_CR103","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.maturitas.2016.11.012","volume":"96","author":"K Mikkelsen","year":"2017","unstructured":"Mikkelsen K, Stojanovska L, Prakash M, Apostolopoulos V (2017) The effects of vitamin B on the immune\/cytokine network and their involvement in depression. Maturitas 96:58\u201371","journal-title":"Maturitas"},{"key":"1050_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2017.04.011","volume":"155","author":"S Miranda","year":"2017","unstructured":"Miranda S, Le Cam-Duchez V, Benichou J, Donnadieu N, Barbay V, Le Besnerais M, Delmas F-X, Cuvelier A, L\u00e9vesque H, Benhamou Y (2017) Adjusted value of thromboprophylaxis in hospitalized obese patients: a comparative study of two regimens of enoxaparin: the ITOHENOX study. Thromb Res 155:1\u20135","journal-title":"Thromb Res"},{"issue":"4","key":"1050_CR105","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/antibiotics9040196","volume":"9","author":"S Morris","year":"2020","unstructured":"Morris S, Cerceo E (2020) Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics 9(4):196","journal-title":"Antibiotics"},{"issue":"5","key":"1050_CR106","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ppul.23956","volume":"53","author":"RA Mosquera","year":"2018","unstructured":"Mosquera RA, De Jesus-Rojas W, Stark JM, Yadav A, Jon CK, Atkins CL, Samuels CL, Gonzales TR, McBeth KE, Hashmi SS (2018) Role of prophylactic azithromycin to reduce airway inflammation and mortality in a RSV mouse infection model. Pediatr Pulmonol 53(5):567\u2013574","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"1050_CR107","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.26719\/2013.19.supp1.S19","volume":"19","author":"A Mounts","year":"2013","unstructured":"Mounts A, De La Rocque S, Fitzner J, Garcia E, Thomas H, Brown D, Schuster H, Vandemaele K, Esmat H, Eremin S (2013) The early response to a novel coronavirus in the Middle East. EMHJ-East Mediterr Health J 19(1):S19\u2013S25","journal-title":"EMHJ-East Mediterr Health J"},{"issue":"7","key":"1050_CR108","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1080\/07391102.2020.1752802","volume":"39","author":"N Muralidharan","year":"2021","unstructured":"Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM (2021) Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dyn 39(7):2673\u20132678","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"1050_CR109","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/eri.10.35","volume":"8","author":"AM Noreddin","year":"2010","unstructured":"Noreddin AM, Elkhatib WF (2010) Levofloxacin in the treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther 8(5):505\u2013514","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1050_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2021-RCPCH.119","author":"L Noronha","year":"2021","unstructured":"Noronha L, Arasu A, Crook J (2021) 220 Use of paracetamol for closure of patent ductus arteriosus in premature infants in a level 3 NICU. BMJ Spec J. https:\/\/doi.org\/10.1136\/bmjpo-2021-RCPCH.119","journal-title":"BMJ Spec J"},{"issue":"1","key":"1050_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11239-015-1314-3","volume":"41","author":"EA Nutescu","year":"2016","unstructured":"Nutescu EA, Burnett A, Fanikos J, Spinler S, Wittkowsky A (2016) Pharmacology of anticoagulants used in the treatment of venous thromboembolism. J Thromb Thrombolysis 41(1):15\u201331","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"1050_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30099-2","volume":"5","author":"A Odone","year":"2020","unstructured":"Odone A, Delmonte D, Scognamiglio T, Signorelli C (2020) COVID-19 deaths in Lombardy, Italy: data in context. The Lancet Public Health 5(6):e310","journal-title":"The Lancet Public Health"},{"key":"1050_CR113","volume-title":"Clinical management of COVID-19: interim guidance","author":"Organization W. H.","year":"2020","unstructured":"Organization W. H. (2020a) Clinical management of COVID-19: interim guidance. World Health Organization"},{"key":"1050_CR114","volume-title":"Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief","author":"Organization W.H.","year":"2020","unstructured":"Organization W.H. (2020b) Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief. World Health Organization"},{"issue":"6575","key":"1050_CR115","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen DR, Allerton CM, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ (2021) An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 374(6575):1586\u20131593","journal-title":"Science"},{"issue":"3","key":"1050_CR116","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41390-019-0557-7","volume":"87","author":"M Ozen","year":"2020","unstructured":"Ozen M, Xie H, Shin N, Al Yousif G, Clemens J, McLane MW, Lei J, Burd I (2020) Magnesium sulfate inhibits inflammation through P2X7 receptors in human umbilical vein endothelial cells. Pediatr Res 87(3):463\u2013471","journal-title":"Pediatr Res"},{"key":"1050_CR117","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11481-020-09923-w","volume":"15","author":"P Pahan","year":"2020","unstructured":"Pahan P, Pahan K (2020) Smooth or risky revisit of an old malaria drug for COVID-19? J Neuroimmune Pharmacol 15:174\u2013180","journal-title":"J Neuroimmune Pharmacol"},{"key":"1050_CR118","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00121.2016","author":"BF Palmer","year":"2016","unstructured":"Palmer BF, Clegg DJ (2016) Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. https:\/\/doi.org\/10.1152\/advan.00121.2016","journal-title":"Adv Physiol Educ"},{"issue":"5","key":"1050_CR119","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.ajkd.2019.03.427","volume":"74","author":"BF Palmer","year":"2019","unstructured":"Palmer BF, Clegg DJ (2019) Physiology and pathophysiology of potassium homeostasis: core curriculum 2019. Am J Kidney Dis 74(5):682\u2013695","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1050_CR120","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/jcm9040967","volume":"9","author":"M Park","year":"2020","unstructured":"Park M, Cook AR, Lim JT, Sun Y, Dickens BL (2020a) A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med 9(4):967","journal-title":"J Clin Med"},{"issue":"3","key":"1050_CR121","doi-asserted-by":"publisher","first-page":"e01114","DOI":"10.1128\/mBio.01114-20","volume":"11","author":"S-J Park","year":"2020","unstructured":"Park S-J, Yu K-M, Kim Y-I, Kim S-M, Kim E-H, Kim S-G, Kim EJ, Casel MAB, Rollon R, Jang S-G (2020b) Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets. Mbio 11(3):e01114-01120","journal-title":"Mbio"},{"issue":"3","key":"1050_CR122","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/ije\/dyaa033","volume":"49","author":"NC Peeri","year":"2020","unstructured":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U (2020) The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 49(3):717\u2013726","journal-title":"Int J Epidemiol"},{"issue":"10","key":"1050_CR123","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C9MD00120D","volume":"10","author":"TD Pham","year":"2019","unstructured":"Pham TD, Ziora ZM, Blaskovich MA (2019) Quinolone antibiotics. MedChemComm 10(10):1719\u20131739","journal-title":"MedChemComm"},{"issue":"14","key":"1050_CR124","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar T, Manickam M, Namasivayam V, Hayashi Y, Jung S-H (2016) An overview of severe acute respiratory syndrome\u2013coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J Med Chem 59(14):6595\u20136628","journal-title":"J Med Chem"},{"unstructured":"Podder V, Sadiq NM (2019) Levofloxacin. StatPearls, pp 1\u20132. https:\/\/europepmc.org\/article\/nbk\/nbk545180","key":"1050_CR125"},{"issue":"10","key":"1050_CR126","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tips.2009.07.005","volume":"30","author":"R Polosa","year":"2009","unstructured":"Polosa R, Blackburn MR (2009) Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 30(10):528\u2013535","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1050_CR127","doi-asserted-by":"publisher","DOI":"10.2196\/25830","volume":"23","author":"L Post","year":"2021","unstructured":"Post L, Marogi E, Moss CB, Murphy RL, Ison MG, Achenbach CJ, Resnick D, Singh L, White J, Boctor MJ, Welch SB, Oehmke JF (2021) SARS-CoV-2 surveillance in the Middle East and North Africa: longitudinal trend analysis. J Med Internet Res 23(1):e25830","journal-title":"J Med Internet Res"},{"issue":"4","key":"1050_CR128","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1183\/09031936.95.08040637","volume":"8","author":"K Rabe","year":"1995","unstructured":"Rabe K, Magnussen H, Dent G (1995) Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 8(4):637\u2013642","journal-title":"Eur Respir J"},{"issue":"1","key":"1050_CR129","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA (2016) Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin 42(1):15\u201331","journal-title":"Rheum Dis Clin"},{"issue":"9","key":"1050_CR130","first-page":"2459","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A (2020) Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 71(9):2459\u20132468","journal-title":"Clin Infect Dis"},{"issue":"50","key":"1050_CR131","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1073\/pnas.1618029113","volume":"113","author":"H Retallack","year":"2016","unstructured":"Retallack H, Di Lullo E, Arias C, Knopp KA, Laurie MT, Sandoval-Espinosa C, Leon WRM, Krencik R, Ullian EM, Spatazza J (2016) Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci 113(50):14408\u201314413","journal-title":"Proc Natl Acad Sci"},{"issue":"10223","key":"1050_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet (london, England) 395(10223):e30","journal-title":"Lancet (london, England)"},{"key":"1050_CR133","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.40","volume":"44","author":"SGV Rosa","year":"2020","unstructured":"Rosa SGV, Santos WC (2020) Clinical trials on drug repositioning for COVID-19 treatment. Rev Panam Salud Publica 44:e40","journal-title":"Rev Panam Salud Publica"},{"key":"1050_CR134","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tranpol.2021.06.003","volume":"110","author":"W Rothengatter","year":"2021","unstructured":"Rothengatter W, Zhang J, Hayashi Y, Nosach A, Wang K, Oum TH (2021) Pandemic waves and the time after covid-19\u2013consequences for the transport sector. Transp Policy 110:225\u2013237","journal-title":"Transp Policy"},{"issue":"11","key":"1050_CR135","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/phar.2627","volume":"41","author":"M Rubio-Rivas","year":"2021","unstructured":"Rubio-Rivas M, Forero CG, Mora-Luj\u00e1n JM, Montero A, Formiga F, Homs NA, Alb\u00e0-Albalate J, S\u00e1nchez L, Rello J, Corbella X (2021) Beneficial and harmful outcomes of tocilizumab in severe COVID-19: a systematic review and meta-analysis. Pharmacother J Hum Pharmacol Drug Ther 41(11):884\u2013906","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"10223","key":"1050_CR136","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet 395(10223):473\u2013475","journal-title":"The Lancet"},{"issue":"1","key":"1050_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.102717","volume":"59","author":"W Sabry","year":"2020","unstructured":"Sabry W, Elemary M, Burnouf T, Seghatchian J, Goubran H (2020) Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA). Transfus Apheres Sci 59(1):102717","journal-title":"Transfus Apheres Sci"},{"issue":"6","key":"1050_CR138","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.arcmed.2020.05.001","volume":"51","author":"A Saha","year":"2020","unstructured":"Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee S-S, Chakraborty C (2020) Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more. Arch Med Res 51(6):585\u2013586","journal-title":"Arch Med Res"},{"issue":"4","key":"1050_CR139","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.033","volume":"82","author":"S Saito","year":"2020","unstructured":"Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Tsuzuki S, Ohmagari N (2020) First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics: comparison of the two COVID-19 waves in Japan. J Infect 82(4):84\u2013123","journal-title":"J Infect"},{"key":"1050_CR140","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac180","author":"LD Saravolatz","year":"2022","unstructured":"Saravolatz LD, Depcinski S, Sharma M (2022) Molnupiravir and nirmatrelvir-ritonavir: oral COVID antiviral drugs. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciac180","journal-title":"Clin Infect Dis"},{"key":"1050_CR141","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fpubh.2020.00209","volume":"8","author":"T Sawaya","year":"2020","unstructured":"Sawaya T, Ballouz T, Zaraket H, Rizk N (2020) Coronavirus disease (COVID-19) in the Middle East: a call for a unified response. Front Public Health 8:209","journal-title":"Front Public Health"},{"issue":"3","key":"1050_CR142","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"1050_CR143","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 16(12):843\u2013862","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1050_CR144","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/v13010008","volume":"13","author":"SL Scroggs","year":"2021","unstructured":"Scroggs SL, Offerdahl DK, Flather DP, Morris CN, Kendall BL, Broeckel RM, Beare PA, Bloom ME (2021) Fluoroquinolone antibiotics exhibit low antiviral activity against SARS-CoV-2 and MERS-CoV. Viruses 13(1):8","journal-title":"Viruses"},{"issue":"6","key":"1050_CR145","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jinf.2020.09.024","volume":"81","author":"RA Seaton","year":"2020","unstructured":"Seaton RA, Gibbons CL, Cooper L, Malcolm W, McKinney R, Dundas S, Griffith D, Jeffreys D, Hamilton K, Choo-Kang B (2020) Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect 81(6):952\u2013960","journal-title":"J Infect"},{"issue":"10","key":"1050_CR146","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.2020.15725","volume":"324","author":"A Shah","year":"2020","unstructured":"Shah A, Marks PW, Hahn SM (2020) Unwavering regulatory safeguards for COVID-19 vaccines. JAMA 324(10):931\u2013932","journal-title":"JAMA"},{"issue":"1","key":"1050_CR147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-019-0618-4","volume":"10","author":"Y Shang","year":"2020","unstructured":"Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X (2020) Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intens Care 10(1):1\u201324","journal-title":"Ann Intens Care"},{"issue":"1","key":"1050_CR148","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1152\/ajprenal.00119.2002","volume":"284","author":"SS Shankar","year":"2003","unstructured":"Shankar SS, Brater DC (2003) Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol-Renal Physiol 284(1):F11\u2013F21","journal-title":"Am J Physiol-Renal Physiol"},{"key":"1050_CR149","first-page":"e00487","volume":"91","author":"A Shannon","year":"2020","unstructured":"Shannon A, Selisko B, Le N, Huchting J, Touret F, Piorkowski G, Fattorini V, Ferron F, Decroly E, Meier C (2020d) Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase. BioRxiv 91:e00487","journal-title":"BioRxiv"},{"issue":"1","key":"1050_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"TP Sheahan","year":"2020","unstructured":"Sheahan TP, Sims AC, Leist SR, Sch\u00e4fer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 11(1):1\u201314","journal-title":"Nat Commun"},{"issue":"1","key":"1050_CR151","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaci.2020.08.031","volume":"147","author":"JT Sims","year":"2021","unstructured":"Sims JT, Krishnan V, Chang C-Y, Engle SM, Casalini G, Rodgers GH, Bivi N, Nickoloff BJ, Konrad RJ, de Bono S (2021) Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol 147(1):107\u2013111","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1050_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102396","volume":"16","author":"AK Singh","year":"2022","unstructured":"Singh AK, Singh A, Singh R, Misra A (2022) An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19. Diabetes Metab Syndr 16(2):102396","journal-title":"Diabetes Metab Syndr"},{"issue":"1145","key":"1050_CR153","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/postgradmedj-2020-138080","volume":"97","author":"N Sisti","year":"2021","unstructured":"Sisti N, Valente S, Mandoli GE, Santoro C, Sciaccaluga C, Franchi F, Cameli P, Mondillo S, Cameli M (2021) COVID-19 in patients with heart failure: the new and the old epidemic. Postgrad Med J 97(1145):175\u2013179","journal-title":"Postgrad Med J"},{"issue":"3","key":"1050_CR154","doi-asserted-by":"publisher","first-page":"324","DOI":"10.24170\/17-3-4379","volume":"17","author":"F Smit","year":"2020","unstructured":"Smit F, Oelofse A, Linegar A, Hanekom H, Botes L, Turton E (2020) Supplemental oxygen therapy in COVID-19. SA Heart 17(3):324\u2013328","journal-title":"SA Heart"},{"issue":"11","key":"1050_CR155","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jama.2020.16349","volume":"324","author":"CD Spinner","year":"2020","unstructured":"Spinner CD, Gottlieb RL, Criner GJ, L\u00f3pez JRA, Cattelan AM, Viladomiu AS, Ogbuagu O, Malhotra P, Mullane KM, Castagna A (2020) Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA 324(11):1048\u20131057","journal-title":"JAMA"},{"issue":"3","key":"1050_CR156","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.161063","volume":"44","author":"A Srinivasa","year":"2017","unstructured":"Srinivasa A, Tosounidou S, Gordon C (2017) Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue? J Rheumatol 44(3):398\u2013398","journal-title":"J Rheumatol"},{"issue":"4","key":"1050_CR157","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","volume":"20","author":"J Stebbing","year":"2020","unstructured":"Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 20(4):400\u2013402","journal-title":"Lancet Infect Dis"},{"key":"1050_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13369","author":"NA Steffens","year":"2021","unstructured":"Steffens NA, Zimmermann ES, Nichelle SM, Brucker N (2021) Meropenem use and therapeutic drug monitoring in clinical practice: a literature review. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.13369","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"1050_CR159","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","volume":"2","author":"V Surveillances","year":"2020","unstructured":"Surveillances V (2020) The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)\u2014China, 2020. China CDC Wkly 2(8):113\u2013122","journal-title":"China CDC Wkly"},{"issue":"15","key":"1050_CR160","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMc2201933","volume":"386","author":"E Takashita","year":"2022","unstructured":"Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Halfmann P, Watanabe S, Maeda K (2022) Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2. N Engl J Med 386(15):1475\u20131477","journal-title":"N Engl J Med"},{"key":"1050_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104257","volume":"104","author":"Q Tan","year":"2020","unstructured":"Tan Q, Duan L, Ma Y, Wu F, Huang Q, Mao K, Xiao W, Xia H, Zhang S, Zhou E (2020) Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Bioorg Chem 104:104257","journal-title":"Bioorg Chem"},{"key":"1050_CR162","doi-asserted-by":"publisher","first-page":"173546","DOI":"10.1016\/j.ejphar.2020.173546","volume":"886","author":"C-F Tang","year":"2020","unstructured":"Tang C-F, Ding H, Jiao R-Q, Wu X-X, Kong L-D (2020) Possibility of magnesium supplementation for supportive treatment in patients with COVID-19. Eur J Pharmacol 886:173546","journal-title":"Eur J Pharmacol"},{"key":"1050_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110018","volume":"143","author":"\u015e Ta\u015ftemur","year":"2020","unstructured":"Ta\u015ftemur \u015e, Ataseven H (2020) Is it possible to use proton pump inhibitors in COVID-19 treatment and prophylaxis? Med Hypotheses 143:110018","journal-title":"Med Hypotheses"},{"issue":"7","key":"1050_CR164","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","volume":"182","author":"Y To","year":"2010","unstructured":"To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM, Barnes PJ (2010) Targeting phosphoinositide-3-kinase-\u03b4 with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182(7):897\u2013904","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1050_CR165","doi-asserted-by":"publisher","first-page":"071","DOI":"10.1093\/jacamr\/dlaa071","volume":"2","author":"L Townsend","year":"2020","unstructured":"Townsend L, Hughes G, Kerr C, Kelly M, O\u2019Connor R, Sweeney E, Doyle C, O\u2019Riordan R, Martin-Loeches I, Bergin C (2020) Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-Antimicrob Resist 2(3):071","journal-title":"JAC-Antimicrob Resist"},{"issue":"10","key":"1050_CR166","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41429-019-0204-x","volume":"72","author":"DH Tran","year":"2019","unstructured":"Tran DH, Sugamata R, Hirose T, Suzuki S, Noguchi Y, Sugawara A, Ito F, Yamamoto T, Kawachi S, Akagawa KS (2019) Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A (H1N1) pdm09 virus infection by interfering with virus internalization process. J Antibiot 72(10):759\u2013768","journal-title":"J Antibiot"},{"issue":"24","key":"1050_CR167","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1001\/jama.2020.8917","volume":"323","author":"B Trogen","year":"2020","unstructured":"Trogen B, Oshinsky D, Caplan A (2020) Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA 323(24):2460\u20132461","journal-title":"JAMA"},{"issue":"1","key":"1050_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-00703-5","volume":"28","author":"IP Trougakos","year":"2021","unstructured":"Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, Kastritis E, Pavlakis GN, Dimopoulos MA (2021) Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci 28(1):1\u201318","journal-title":"J Biomed Sci"},{"issue":"3","key":"1050_CR169","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/0022-3859.57411","volume":"55","author":"M Tullu","year":"2009","unstructured":"Tullu M (2009) Oseltamivir. J Postgrad Med 55(3):225","journal-title":"J Postgrad Med"},{"issue":"6","key":"1050_CR170","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10156-009-0728-2","volume":"15","author":"T Ubagai","year":"2009","unstructured":"Ubagai T, Koshibu Y, Koshio O, Ono Y, Nakaki T (2009) Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole. J Infect Chemother 15(6):374\u2013379","journal-title":"J Infect Chemother"},{"key":"1050_CR172","doi-asserted-by":"publisher","first-page":"110668","DOI":"10.1016\/j.biopha.2020.110668","volume":"131","author":"K Uzunova","year":"2020","unstructured":"Uzunova K, Filipova E, Pavlova V, Vekov T (2020) Insights into antiviral mechanisms of remdesivir, lopinavir\/ritonavir and chloroquine\/hydroxychloroquine affecting the new SARS-CoV-2. Biomed Pharmacother 131:110668","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1050_CR173","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19(3):155\u2013170","journal-title":"Nat Rev Microbiol"},{"issue":"13","key":"1050_CR174","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1080\/14656566.2018.1512583","volume":"19","author":"M van Gameren","year":"2018","unstructured":"van Gameren M, Lemmert M, Wilschut J, Daemen J, De Jaegere P, Zijlstra F, Van Mieghem N, Diletti R (2018) An update on the use of anticoagulant therapy in ST-segment elevation myocardial infarction. Expert Opin Pharmacother 19(13):1441\u20131450","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1050_CR175","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gut.33.5.617","volume":"33","author":"J Wandall","year":"1992","unstructured":"Wandall J (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33(5):617\u2013621","journal-title":"Gut"},{"issue":"11","key":"1050_CR176","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA 323(11):1061\u20131069","journal-title":"JAMA"},{"issue":"1","key":"1050_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-02895-6","volume":"24","author":"D Wang","year":"2020","unstructured":"Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, Jian M, Xu H, Prowle J, Hu B (2020b) Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care 24(1):1\u20139","journal-title":"Crit Care"},{"issue":"10236","key":"1050_CR178","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q (2020c) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395(10236):1569\u20131578","journal-title":"Lancet"},{"issue":"suppl_1","key":"1050_CR179","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/dki018","volume":"55","author":"P Ward","year":"2005","unstructured":"Ward P, Small I, Smith J, Suter P, Dutkowski R (2005) Oseltamivir (Tamiflu\u00ae) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55(suppl_1):5\u201321","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1050_CR180","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2019.05.013","volume":"515","author":"G Wei","year":"2019","unstructured":"Wei G, Sun R, Xu T, Kong S, Zhang S (2019) Aminophylline promotes mitochondrial biogenesis in human pulmonary bronchial epithelial cells. Biochem Biophys Res Commun 515(1):31\u201336","journal-title":"Biochem Biophys Res Commun"},{"unstructured":"WHO (2022) WHO coronavirus (COVID-19) dashboard. Retrieved 17 Jul 2022","key":"1050_CR181"},{"unstructured":"Worldometer\/Saudi Arabia United Nations (2022) Department of Economic and Social Affairs, Population Division. Retrieved 17 July 2022","key":"1050_CR182"},{"issue":"10","key":"1050_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006848","volume":"12","author":"Y-H Wu","year":"2018","unstructured":"Wu Y-H, Tseng C-K, Lin C-K, Wei C-K, Lee J-C, Young K-C (2018) ICR suckling mouse model of Zika virus infection for disease modeling and drug validation. PLoS Negl Trop Dis 12(10):e0006848","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1050_CR184","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180(7):934\u2013943","journal-title":"JAMA Intern Med"},{"issue":"10","key":"1050_CR185","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2020.15543","volume":"324","author":"S Xia","year":"2020","unstructured":"Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W (2020) Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA 324(10):951\u2013960","journal-title":"JAMA"},{"issue":"2","key":"1050_CR186","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","volume":"81","author":"Y Xie","year":"2020","unstructured":"Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W, Yang L, Fu S, Wang R (2020) Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect 81(2):318","journal-title":"J Infect"},{"issue":"31","key":"1050_CR187","doi-asserted-by":"publisher","first-page":"e11384","DOI":"10.1097\/MD.0000000000011384","volume":"97","author":"J Xing","year":"2018","unstructured":"Xing J, Yin X, Chen D (2018) Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer: a meta-analysis. Medicine 97(31):e11384","journal-title":"Medicine"},{"issue":"1","key":"1050_CR188","doi-asserted-by":"publisher","first-page":"2000799","DOI":"10.1183\/13993003.00799-2020","volume":"56","author":"D Yan","year":"2020","unstructured":"Yan D, Liu X-Y, Zhu Y-N, Huang L, Dan B-T, Zhang G-J, Gao Y-H (2020) Factors associated with prolonged viral shedding and impact of lopinavir\/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Eur Respir J 56(1):2000799","journal-title":"Eur Respir J"},{"issue":"6","key":"1050_CR189","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jmv.25729","volume":"92","author":"TT Yao","year":"2020","unstructured":"Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ (2020) A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus\u2014a possible reference for coronavirus disease-19 treatment option. J Med Virol 92(6):556\u2013563","journal-title":"J Med Virol"},{"issue":"6","key":"1050_CR190","first-page":"3390","volume":"24","author":"X Ye","year":"2020","unstructured":"Ye X, Luo Y, Xia S, Sun Q, Ding J, Zhou Y, Chen W, Wang X, Zhang W, Du W (2020) Clinical efficacy of lopinavir\/ritonavir in the treatment of Coronavirus disease 2019. Eur Rev Med Pharmacol Sci 24(6):3390\u20133396","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1050_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09924-7","volume":"20","author":"JY Yoo","year":"2020","unstructured":"Yoo JY, Dutra SVO, Fanfan D, Sniffen S, Wang H, Siddiqui J, Song H-S, Bang SH, Kim DE, Kim S (2020) Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti. BMC Public Health 20(1):1\u201316","journal-title":"BMC Public Health"},{"key":"1050_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: a review. Clin Immunol 215:108427","journal-title":"Clin Immunol"},{"unstructured":"Zafar Gondal A, Zulfiqar H (2019) Aminophylline. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545175","key":"1050_CR50"},{"key":"1050_CR193","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","volume":"15","author":"S Zaim","year":"2020","unstructured":"Zaim S, Chong JH, Sankaranarayanan V, Harky A (2020) COVID-19 and multi-organ response. Curr Prob Cardiol 15:100618","journal-title":"Curr Prob Cardiol"},{"issue":"4","key":"1050_CR194","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijantimicag.2018.12.009","volume":"53","author":"S Zeng","year":"2019","unstructured":"Zeng S, Meng X, Huang Q, Lei N, Zeng L, Jiang X, Guo X (2019) Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo. Int J Antimicrob Agents 53(4):362\u2013369","journal-title":"Int J Antimicrob Agents"},{"issue":"1\u20133","key":"1050_CR195","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.theochem.2004.04.065","volume":"681","author":"XW Zhang","year":"2004","unstructured":"Zhang XW, Yap YL (2004) The 3D structure analysis of SARS-CoV S1 protein reveals a link to influenza virus neuraminidase and implications for drug and antibody discovery. J Mol Struct (thoechem) 681(1\u20133):137\u2013141","journal-title":"J Mol Struct (thoechem)"},{"key":"1050_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.10.005","author":"T Zhang","year":"2020","unstructured":"Zhang T, Liu D, Tian D, Xia L (2020e) The roles of nausea and vomiting in COVID-19: did we miss something? J Microbiol Immunol Infect. https:\/\/doi.org\/10.1016\/j.jmii.2020.10.005","journal-title":"J Microbiol Immunol Infect"},{"issue":"18","key":"1050_CR197","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.3390\/ijerph17186692","volume":"17","author":"SZ Zhao","year":"2020","unstructured":"Zhao SZ, Wong JYH, Wu Y, Choi EPH, Wang MP, Lam TH (2020) Social distancing compliance under COVID-19 pandemic and mental health impacts: a population-based study. Int J Environ Res Public Health 17(18):6692","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"1050_CR198","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.7150\/ijbs.45053","volume":"16","author":"J Zheng","year":"2020","unstructured":"Zheng J (2020) SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci 16(10):1678","journal-title":"Int J Biol Sci"},{"issue":"10229","key":"1050_CR199","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062","journal-title":"Lancet"},{"issue":"3","key":"1050_CR200","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiab247","volume":"224","author":"S Zhou","year":"2021","unstructured":"Zhou S, Hill CS, Sarkar S, Tse LV, Woodburn BM, Schinazi RF, Sheahan TP, Baric RS, Heise MT, Swanstrom R (2021) \u03b2-d-N 4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells. J Infect Dis 224(3):415\u2013419","journal-title":"J Infect Dis"},{"key":"1050_CR201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R (2020f) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01050-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T22:58:11Z","timestamp":1669417091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":199,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01050-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}